The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC

• Main Authors: He YY (Author), Liu ST (Author), Mattei J (Author), Bunn Jr PA (Author), Zhou CC (Author), Chan D (Author)
• Format: Book
• Published: Dove Medical Press, 2018-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Yayi He,1,2,* Sangtian Liu,1,* Jane Mattei,3 Paul A Bunn Jr,2 Caicun Zhou,1 Daniel Chan2 1Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China; 2Division of Medical Oncology, Department o...